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Whole-Exome Sequencing Identifies FAM20A
Mutations as a Cause of Amelogenesis Imperfecta
and Gingival Hyperplasia Syndrome
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Sanjeev S. Bhaskar,2 Hercilio Martelli-Ju´nior,4 Pedro Eleuterio dos Santos Neto,4 Maria A. Mansilla,5
Jeffrey C. Murray,5 Ricardo D. Coletta,3 Graeme C.M. Black,1,2,* and Michael J. Dixon1,*
Amelogenesis imperfecta (AI) describes a clinically and genetically heterogeneous group of disorders of biomineralization resulting from
failure of normal enamel formation. AI is found as an isolated entity or as part of a syndrome, and an autosomal-recessive syndrome
associating AI and gingival hyperplasia was recently reported. Using whole-exome sequencing, we identified a homozygous nonsense
mutation in exon 2 of FAM20A that was not present in the Single Nucleotide Polymorphism database (dbSNP), the 1000 Genomes data-
base, or the Centre d’Etude du Polymorphisme Humain (CEPH) Diversity Panel. Expression analyses indicated that Fam20a is expressed
in ameloblasts and gingivae, providing biological plausibility for mutations in FAM20A underlying the pathogenesis of this syndrome.Dental enamel is themost extreme example ofmammalian
biomineralization, with almost 97% of the mature tissue
occupied by unusually large hydroxyapatite crystals that
are organized into prisms; consequently, enamel is the
hardest mineralized tissue in humans.1 A number of in-
herited congenital defects of enamel formation have been
described, together termed amelogenesis imperfecta (AI;
MIM 104530), that provide the opportunity to delineate
the essential events underlying biomineralization and to
dissect the molecular pathogenesis of skeletal disease.2
Collectively, the various forms of AI are common, with
incidence rates as high as 1 in 700 live births reported.3 In
addition, AI results in considerable morbidity, because
affected individuals experience difficulty maintaining oral
hygiene, have lower self-esteem owing to poor dental
aesthetics, and report inferior quality of life.4
AI is characterized bymarked clinical and genetic hetero-
geneity, with at least 14 different subtypes recognized
and with autosomal-dominant, autosomal-recessive, and
X-linked recessive inheritance described.3 To date, six genes
(AMELX, MIM 300391; ENAM, MIM 606585; MMP20,
MIM 604629; KLK4, MIM 603767; FAM83H, MIM 611927;
WDR72, MIM 613214) have been implicated in nonsyn-
dromic forms of AI.5–7 Mutations in two additional genes
have been shown to underlie syndromic AI, with DLX3
mutations causing tricho-dento-osseous syndrome (MIM
190320), an autosomal-dominant disorder characterized
by curly hair at birth, enamel hypoplasia, taurodontism,
and thick cortical bone,5 and CNNM4 mutations resulting
in Jalili syndrome, which comprises autosomal-recessive
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lies. These observations, together with the lack of a consis-
tent genotype-phenotype correlation, complicate genetic
analysis of AI. Recently, whole-exome sequencing has
been demonstrated to be an effective method for the iden-
tification of rare Mendelian disorders;10–13 nevertheless,
considerablebioinformatics challenges remain, and linkage
information together with functional data provide useful
filters for reducing this complexity.14–16
Recently, we reported a large, consanguineous family
affected by a syndrome characterized by dental anomalies
and gingival hyperplasia (Figures 1A and 1B).17 Although
thin generalized hypoplastic AIwas themain dental feature
observed in affected individuals (Figure 1A), intrapulpal
calcifications, delayed tooth eruption, and failure of tooth
development were also observed.17 Although mental retar-
dation was superimposed on the AI and gingival hyper-
plasia in one individual, the observation that this feature
occurred as an isolated entity in six relatives suggested
the segregation of mutations in two independent loci in
this family. DNA samples were obtained from nine
members of the family via standard procedures and with
informed consent under the relevant Institutional Review
Boards and the UK National Research Ethics Service.
Targeted enrichment and sequencing were performed on
3mgofDNAextracted fromperipheral bloodof a single indi-
vidual with AI and gingival hyperplasia. Enrichment was
performed with SureSelect Human All Exon Kit version
one (Agilent) for theABSOLiD system, following themanu-
facturer’s protocols. Electronic PCR was conducted on the
resultant sample library, which was then sequenced acrosss Centre, University of Manchester, Oxford Road, Manchester M13 9PT, UK;
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Figure 1. A Mutation in FAM20A Underlies AI with Gingival Hyperplasia
(A) Clinical pictures of the teeth and gingivae of individuals II-2 and II-3. Affected persons exhibit thin, hypoplastic AI, resulting in
a dentition with yellow discoloration and loss of structure together with enlargement of the gingivae.
(B) Partial pedigree of the family. Shaded symbols represent individuals affected with AI and gingival hyperplasia, with the exception of
individual II-7, who is affected with AI, gingival hyperplasia, andmental retardation. DNA samples were available from those individuals
indicated with an asterisk.
(C) Homozygositymapping showing the homozygous region on chromosome 17 common to affected individuals. Black and yellow bars
indicate homozygous and heterozygous SNPs, respectively.
(D) Sequence chromatograms showing segregation of the c.406C>T mutation with the affected phenotype.twoquads of a flow cell on a SOLiD3þ sequencer (Life Tech-
nologies), following the manufacturer’s protocols.
Sequence data were mapped with SOLiD Bioscope soft-
ware (Life Technologies) and with hg18 human genome
as a reference. SNPs were called with the diBayes tool in
the Bioscope software suite with the Med-Coverage setting
and then filtered for those SNPs with less than 103
coverage. SNPs were annotated with the SeattleSeq annota-
tion tool. A total of 5.4 gigabases of sequence mapped
uniquely to the genome reference hg18, with 90.8% of
the targeted exome covered at 10-fold or higher. On
average, a total of 53-fold coverage was achieved across
the exome (see Table S1 available online).
To reduce the complexity of the bioinformatics analysis,
we performed homozygosity mapping on five individuals
(two affected with AI and gingival hyperplasia, one
affected with AI, gingival hyperplasia, and mental retarda-
tion, one affected with mental retardation only, and one
unaffected). DNA was hybridized to Affymetrix Genome-
Wide Human SNP 6.0 arrays in accordance with the manu-
facturer’s protocol. Briefly, 500 ng total genomic DNA was
digested with NspI and StyI. Primers that recognize theThe Ameadaptor sequences were used to amplify adaptor-ligated
DNA fragments. PCR conditions were optimized to prefer-
entially amplify fragments in the 200–1100 bp size range.
The amplified DNA was fragmented with the Affymetrix
fragmentation reagent to a size of 50–200 bp and was
then labeled and hybridized to a GeneChip Human
Mapping SNP 6.0 array. Genotyping and copy number
analysis were performed with the Genotyping Console
software and Chromosome Analysis Suite (Affymetrix),
respectively. Homozygous regions were identified with
AutoSNPa. The results of this analysis identified a single
region of homozygosity greater than 1 Mb: a 6 Mb interval
flanked by nucleotides 61,966,341–67,925,728 (as defined
by rs2361486 and rs8066872) on human chromosome 17q
in the individuals affected with AI and gingival hyperplasia
(Figure 1C). The individual affected with mental retarda-
tion alone was not homozygous for this region, indicating
that this phenotype results from mutation of a different
locus. Fifty-five genes were contained within this critical
interval, and analysis of the captured exons indicated an
average of 49-fold coverage (Figure S1; Table S1). The
next-largest region of homozygosity, an 800 kb intervalrican Journal of Human Genetics 88, 616–620, May 13, 2011 617
on human chromosome 20q, did not encompass any SNPs
that were not present in dbSNP.
Among the sequence variants identified in the interval
defined by rs2361486 and rs8066872, a single homozygous
C>T transition was noted in exon 2 of FAM20A (MIM
611062) (genomic DNA: Chr17[NCBI 36]:g.64063478C>T;
cDNA: NM_017565.2:c.406C>T), which resulted in the
homozygous nonsense mutation p.Arg136X (Figures S1
and S2). Sanger sequencing confirmed that themutation co-
segregated with the dental phenotype, but not with the
mental retardation (Figure 1D; Table S2). Reanalysis of those
individuals who carried one mutated allele confirmed that
they did not manifest any clinical signs of AI, confirming
autosomal-recessive transmission. Bioinformatics analysis
confirmed that this SNP was not present in either dbSNP or
the1000Genomesdatabase (TableS1).Allelicdiscrimination
PCR analysis (Table S2) further indicated that the mutation
was not present in 952 DNA samples from the CEPH Diver-
sity Panel, including 43 Brazilian individuals, nor in DNA
samples from an additional 159 individuals of Brazilian
ancestry. The mutation underlying the mental retardation
observed in this family has not, to date, been elucidated.
To provide direct biological plausibility for Fam20a play-
ing a role in amelogenesis, we performed in situ hybridiza-
tion of Fam20a mRNA and immunolocalization of the
three FAM20 family members in the mouse incisor tooth,
which, in adult mice, forms and erupts continuously
throughout life, offering access to all stages of enamel
development along the axial length of a single tooth
(Figure 2; Figure S3). Mandibles from 2- to 3-month-old
wild-type mice (n ¼ 4) were dissected following cervical
dislocation and were fixed in neutral buffered formalin at
room temperature for 48 hr. Following fixation, themandi-
bles were decalcified in 0.5 M EDTA, dehydrated through
a graded ethanol series, cleared in chloroform, embedded
as hemi-mandibles in paraffin wax, and sectioned.
For in situ hybridization analysis, a 370 bp fragment of
Fam20a exon 1was PCR amplified (Table S2) and TA cloned
into the pGEM-T Easy vector (Promega), and the resulting
construct was used to synthesize digoxygenin-labeled
Fam20a sense and antisense riboprobes with T7 and SP6
polymerases (Promega) and digoxygenin-conjugated dUTP
(Roche). In situ hybridization was performed as described
previously;18 however, riboprobe binding was detected
immunohistochemically with an alkaline phosphatase-
conjugated, anti-digoxygenin antibody (Roche) followed
by histochemical demonstration of alkaline phosphatase
activity that used BM purple (Roche) as the chromogenic
substrate. In situ hybridization for Fam20a transcripts
with the antisense riboprobe showed expression within
the secretory ameloblasts, stratum intermedium cells, and
the underlying analog of the stratum intermedium
(Figure 2A). Fam20a mRNA expression was also observed
within maturation stage ameloblasts, the associated papil-
lary layer, andconnective tissue bed (Figure2B). In addition,
Fam20a mRNA was detected in the suprabasal cells of the
gingivae (Figure 2C), odontoblasts, and dental pulp cells618 The American Journal of Human Genetics 88, 616–620, May 13,(Figure 2D). In parallel experiments with the Fam20a sense
riboprobe, only background levels of alkaline phosphatase
activity were detected (Figures 2E–2H).
Immunofluorescence analysis was performed with anti-
bodies raised against Fam20a, Fam20b, and Fam20C
(Sigma-Aldrich). Primary antibodies were detected with an
Alexa Fluor 488-conjugated secondary antibody (Invitro-
gen) and mounted in DAPI-containing mountant (Vector
Laboratories). Sections were examinedwith aDMRBmicro-
scope (Leica) with Spot digital camera and associated soft-
ware (RTKE/SE; Diagnostic Instruments). Consistent with
the clinical phenotype of AI and gingival hyperplasia and
with results of the in situ hybridization analysis, Fam20a
was observed throughout the tissues of the mandibular
incisor, including the secretory and maturation stage
ameloblasts (Figures 2I and 2J), the suprabasal layers of
the gingival epithelium (Figure 2K), and the odontoblasts
(Figure2L).Despite thepresenceof a signal sequencewithin
the primary peptide,19 there was only weak immunolabel-
ing of Fam20a in the enamel matrix, suggesting limited
secretionwith localization tonuclei in thematuration stage
enamel organ and gingivae (Figures 2I and 2J).
Little or no immunoreactivity for Fam20b was detected
in the secretory stage enamel organ (Figure S3). In contrast,
weak to moderate Fam20b localization was observed in the
gingivae and odontoblasts (Figure S3), with strong immu-
nolocalization in the cytoplasm of maturation stage
ameloblasts (Figure S3). Fam20c was the only Fam20
member that showed evidence of secretion, being detected
in the matrix of the secretory stage enamel organ and
within the cytoplasm of the ameloblasts (Figure S3). Strong
immunolabeling for Fam20c at this stage of amelogenesis
was observed within the cells adjoining the stratum inter-
medium (a tissue layer analogous to the stellate reticulum
seen in the developing molar; Figure S3). Strong Fam20c
immunoreactivity was seen in the cytoplasm of matura-
tion stage ameloblasts and throughout the noncornified
layers of the gingival epithelium (Figure S3). As with the
other Fam20 proteins, Fam20c was observed in the
cytoplasm of the odontoblasts (Figure S3).
Althoughthe functionofFAM20Aisunknown, thegenetic
results and tissue localization analyses presented here
indicate that FAM20A plays a fundamental role in enamel
development and gingival homeostasis. Although further
functional domains have not been identified, comparative
sequence analysis of the FAM20 protein family has indicated
that the highest homology lies in the C-terminal two-thirds
of the protein.19 Although the p.Arg136X change identified
in FAM20A in the current study would spare the signal
sequence, the entire conserved C-terminal domain would
be lost (Figure S2); nevertheless, the position of the termina-
tion codon in exon 2 is most likely to result in nonsense-
mediated degradation of the mutant transcript and a conse-
quent loss of FAM20A protein.20 Notably, the closely related
FAM20C has been shown to be a secreted, calcium-binding
protein that modulates differentiation of the dentin-
producing odontoblasts,21 and loss-of-function mutations2011
Figure 2. In Situ Hybridization of Fam20a and Immunolocalization of Fam20a in the Mouse Mandibular Incisor
(A) Fam20a mRNA expression is observed in the secretory ameloblasts, stratum intermedium, and stellate reticulum analog.
(B)Fam20amRNAisalsoexpressed in thematurationstage ameloblasts, papillary layer, and thecellsof theunderlyingconnective tissuebed.
(C and D) Fam20a is also expressed in the suprabasal layers of the gingivae (C) and in the odontoblasts (D).
(E–H)The specificityof the in situhybridization isdemonstratedbyuseof aFam20a sense riboprobe,whichproducesonlybackground levels
of alkaline phosphatase activity.
(I–L)Consistent with the results of the in situ hybridization analysis, Fam20a immunoreactivity was observed in the secretory (I) andmatu-
ration (J) stage ameloblasts, the suprabasal layers of the gingival epithelium (K), and the odontoblasts (L).
(M–P) The specificity of the immunolabeling is demonstratedbyuse of nonimmune serum,whichproduces only autofluorescence in eryth-
rocytes (asterisks). For immunofluorescence, sections were counterstained withDAPI. The following abbreviations are used: a, ameloblasts;
b, basal cell layer; c, cornified layer; ct, connective tissue bed; dp, dental pulp; o, odontoblasts; p, papillary layer; sb, suprabasal layer; si,
stratum intermedium; sr, stellate reticulum analog. Scale bars represent 50 mm (C, G, I–P) and 25 mm (A, B, D, E, F, H).in this protein result in the autosomal-recessive lethal
osteosclerotic bone dysplasia Raine syndrome, indicating
that this protein plays a crucial role in mineralization.22
The nonsynonymous mutations found in this condition
fall exclusively in the conserved C-terminal domain.22
Recently, a transgenic mouse line with a 58 kb deletion that
encompasses part of Fam20a and its upstream region was
shown to exhibit cessation of growth 5 weeks after birth;23
analysis of the dentition of these mice may provide further
insights into the role of Fam20a during amelogenesis.
In summary, we report the use of whole-exome
sequencing to elucidate the molecular basis of a syndrome
that encompasses AI. Importantly, this study illustrates the
utility of this approach in finding rare mutations in single
families affected by conditions that are characterized byThe Ameextreme phenotypic variability and genetic heterogeneity,
particularly when combined with methods for reducing
the complexity of data analysis such as homozygosity
mapping.Supplemental Data
Supplemental Data include three figures and two tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
We express our gratitude to the family members for participating
in the study and to Aline Petrin, University of Iowa, for collection
of the control DNA samples from Brazilian individuals. We grate-
fully acknowledge financial support from the Wellcome Trustrican Journal of Human Genetics 88, 616–620, May 13, 2011 619
(075945, 093113), the National Institute for Health Research
Manchester Biomedical Research Centre, the State Minas Gerais
Research Foundation (Fundac¸a˜o de Amparo a` Pesquisa do Estado
de Minas Gerais), and the Brazil National Council for Scientific
and Technological Development (CNPq). C.C.B. was supported
by grants from Fundac¸a˜o Coordenac¸a˜o de Aperfeic¸oamento de
Pessoal de Nı´vel Superior (Coordenac¸a˜o de Aperfeic¸oamento de
Pessoal de Nı´vel Superior), Brazil.
Received: February 9, 2011
Revised: April 3, 2011
Accepted: April 8, 2011
Published online: May 5, 2011
Web Resources
The URLs for data presented herein are as follows:
AutoSNPa, http://www.autozygosity.org
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim
SeattleSeq annotation tool, http://gvs.gs.washington.edu/
SeattleSeqAnnotation/HelpAbout.jspReferences
1. Smith, C.E. (1998). Cellular and chemical events during
enamel maturation. Crit. Rev. Oral Biol. Med. 9, 128–161.
2. Hu, J.C., Chun, Y.H., Al Hazzazzi, T., and Simmer, J.P. (2007).
Enamel formation and amelogenesis imperfecta. Cells Tissues
Organs (Print) 186, 78–85.
3. Ba¨ckman, B., and Holm, A.K. (1986). Amelogenesis imper-
fecta: Prevalence and incidence in a northern Swedish county.
Community Dent. Oral Epidemiol. 14, 43–47.
4. Coffield, K.D., Phillips, C., Brady, M., Roberts, M.W., Strauss,
R.P., andWright, J.T. (2005). The psychosocial impact of devel-
opmental dental defects in people with hereditary amelogen-
esis imperfecta. J. Am. Dent. Assoc. 136, 620–630.
5. Stephanopoulos, G., Garefalaki, M.E., and Lyroudia, K. (2005).
Genes and related proteins involved in amelogenesis imper-
fecta. J. Dent. Res. 84, 1117–1126.
6. Kim, J.W., Lee, S.K., Lee, Z.H., Park, J.C., Lee, K.E., Lee, M.H.,
Park, J.T., Seo, B.M., Hu, J.C., and Simmer, J.P. (2008). FAM83H
mutations in families with autosomal-dominant hypocalcified
amelogenesis imperfecta. Am. J. Hum. Genet. 82, 489–494.
7. El-Sayed, W., Parry, D.A., Shore, R.C., Ahmed, M., Jafri, H., Ra-
shid, Y., Al-Bahlani, S., Al Harasi, S., Kirkham, J., Inglehearn,
C.F., and Mighell, A.J. (2009). Mutations in the beta propeller
WDR72 cause autosomal-recessive hypomaturation amelo-
genesis imperfecta. Am. J. Hum. Genet. 85, 699–705.
8. Parry, D.A., Mighell, A.J., El-Sayed, W., Shore, R.C., Jalili, I.K.,
Dollfus, H., Bloch-Zupan, A., Carlos, R., Carr, I.M., Downey,
L.M., et al. (2009).Mutations inCNNM4 cause Jalili syndrome,
consisting of autosomal-recessive cone-rod dystrophy and
amelogenesis imperfecta. Am. J. Hum. Genet. 84, 266–273.
9. Polok, B., Escher, P., Ambresin, A., Chouery, E., Bolay, S., Meu-
nier, I., Nan, F., Hamel, C., Munier, F.L., Thilo, B., et al. (2009).
Mutations inCNNM4 cause recessive cone-rod dystrophywith
amelogenesis imperfecta. Am. J. Hum. Genet. 84, 259–265.
10. Walsh, T., Shahin, H., Elkan-Miller, T., Lee, M.K., Thornton,
A.M., Roeb, W., Abu Rayyan, A., Loulus, S., Avraham, K.B.,
King, M.C., and Kanaan, M. (2010). Whole exome sequencing
and homozygosity mapping identify mutation in the cell620 The American Journal of Human Genetics 88, 616–620, May 13,polarity protein GPSM2 as the cause of nonsyndromic hearing
loss DFNB82. Am. J. Hum. Genet. 87, 90–94.
11. Ng, S.B., Buckingham, K.J., Lee, C., Bigham, A.W., Tabor, H.K.,
Dent, K.M., Huff, C.D., Shannon, P.T., Jabs, E.W., Nickerson,
D.A., et al. (2010). Exome sequencing identifies the cause of
a mendelian disorder. Nat. Genet. 42, 30–35.
12. Hoischen, A., van Bon, B.W., Gilissen, C., Arts, P., van Lier, B.,
Steehouwer, M., de Vries, P., de Reuver, R., Wieskamp, N.,
Mortier, G., et al. (2010). De novo mutations of SETBP1 cause
Schinzel-Giedion syndrome. Nat. Genet. 42, 483–485.
13. Krawitz, P.M., Schweiger, M.R., Ro¨delsperger, C., Marcelis, C.,
Ko¨lsch, U., Meisel, C., Stephani, F., Kinoshita, T., Murakami,
Y., Bauer, S., et al. (2010). Identity-by-descentfilteringof exome
sequence data identifies PIGV mutations in hyperphosphata-
sia mental retardation syndrome. Nat. Genet. 42, 827–829.
14. Ng, S.B., Bigham, A.W., Buckingham, K.J., Hannibal, M.C.,
McMillin, M.J., Gildersleeve, H.I., Beck, A.E., Tabor, H.K.,
Cooper, G.M., Mefford, H.C., et al. (2010). Exome sequencing
identifies MLL2 mutations as a cause of Kabuki syndrome.
Nat. Genet. 42, 790–793.
15. Otto, E.A., Hurd, T.W., Airik, R., Chaki, M., Zhou, W., Stoetzel,
C., Patil, S.B., Levy, S., Ghosh, A.K., Murga-Zamalloa, C.A.,
et al. (2010). Candidate exome capture identifies mutation
of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat.
Genet. 42, 840–850.
16. Funari, V.A., Krakow, D., Nevarez, L., Chen, Z., Funari, T.L.,
Vatanavicharn, N., Wilcox, W.R., Rimoin, D.L., Nelson, S.F.,
and Cohn, D.H. (2010). BMPER mutation in diaphanospon-
dylodysostosis identified by ancestral autozygosity mapping
and targeted high-throughput sequencing. Am. J. Hum.
Genet. 87, 532–537.
17. Martelli-Ju´nior, H., Bonan, P.R., Dos Santos, L.A., Santos, S.M.,
Cavalcanti, M.G., and Coletta, R.D. (2008). Case reports of
a new syndrome associating gingival fibromatosis and dental
abnormalities in a consanguineous family. J. Periodontol.
79, 1287–1296.
18. Knight, A.S., Schutte, B.C., Jiang, R., and Dixon, M.J. (2006).
Developmental expression analysis of themouse and chick or-
thologues of IRF6: The gene mutated in Van der Woude
syndrome. Dev. Dyn. 235, 1441–1447.
19. Nalbant, D., Youn, H., Nalbant, S.I., Sharma, S., Cobos, E.,
Beale, E.G., Du, Y., and Williams, S.C. (2005). FAM20: An
evolutionarily conserved family of secreted proteins expressed
in hematopoietic cells. BMC Genomics 6, 11.
20. Frischmeyer, P.A., and Dietz, H.C. (1999). Nonsense-mediated
mRNA decay in health and disease. Hum. Mol. Genet. 8,
1893–1900.
21. Hao, J., Narayanan, K., Muni, T., Ramachandran, A., and
George, A. (2007). Dentin matrix protein 4, a novel secretory
calcium-binding protein that modulates odontoblast differen-
tiation. J. Biol. Chem. 282, 15357–15365.
22. Simpson, M.A., Hsu, R., Keir, L.S., Hao, J., Sivapalan, G., Ernst,
L.M., Zackai, E.H., Al-Gazali, L.I., Hulskamp, G., Kingston,
H.M., et al. (2007). Mutations in FAM20C are associated
with lethal osteosclerotic bone dysplasia (Raine syndrome),
highlighting a crucial molecule in bone development. Am. J.
Hum. Genet. 81, 906–912.
23. An, C., Ide, Y., Nagano-Fujii, M., Kitazawa, S., Shoji, I., and
Hotta, H. (2010). A transgenic mouse line with a 58-kb frag-
ment deletion in chromosome 11E1 that encompasses part
of the Fam20a gene and its upstream region shows growth
disorder. Kobe J. Med. Sci. 55, E82–E92.2011
